ASX:AGNPharmaceuticals
Argenica Therapeutics (ASX:AGN) Is In A Good Position To Deliver On Growth Plans
We can readily understand why investors are attracted to unprofitable companies. By way of example, Argenica...
ASX:MYXPharmaceuticals
Mayne Pharma Group Limited's (ASX:MYX) market cap touched AU$652m last week, benefiting both individual investors who own 56% as well as institutions
A look at the shareholders of Mayne Pharma Group Limited ( ASX:MYX ) can tell us which group is most powerful. The...
ASX:RNOPharmaceuticals
Insiders may be rethinking their AU$2.2m Rhinomed Limited (ASX:RNO) investment now that the company has lost AU$5.7m in value
The recent price decline of 11% in Rhinomed Limited's ( ASX:RNO ) stock may have disappointed insiders who bought...
ASX:IHLPharmaceuticals
Incannex Healthcare Limited's (ASX:IHL) 18% gain last week benefited both individual investors who own 55% as well as insiders
A look at the shareholders of Incannex Healthcare Limited ( ASX:IHL ) can tell us which group is most powerful. And the...
ASX:SPLPharmaceuticals
Insiders purchases in Starpharma Holdings Limited (ASX:SPL) last year yet to pay off, remain down AU$65k despite recent gains
Insiders who bought AU$168k worth of Starpharma Holdings Limited ( ASX:SPL ) stock in the last year recovered part of...
ASX:IDTPharmaceuticals
After a 15% dip, insiders are undoubtedly glad they sold IDT Australia Limited (ASX:IDT)
Over the past year, insiders sold AU$175k worth of IDT Australia Limited ( ASX:IDT ) stock at an average price of...
ASX:RCEPharmaceuticals
We're Hopeful That Recce Pharmaceuticals (ASX:RCE) Will Use Its Cash Wisely
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...
ASX:NEUPharmaceuticals
The five-year returns have been incredible for Neuren Pharmaceuticals (ASX:NEU) shareholders despite underlying losses increasing
We think all investors should try to buy and hold high quality multi-year winners. And we've seen some truly amazing...
ASX:PXSPharmaceuticals
Pharmaxis Ltd (ASX:PXS) insiders recover some losses but still AU$33k away from matching original investment
Insiders who purchased AU$113k worth of Pharmaxis Ltd ( ASX:PXS ) shares over the past year recouped some of their...